Main public logs

Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

20:41, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/1/ja (Created page with "{{chembox | Verifiedfields = changed | verifiedrevid = 480474501 | ImageFile = Calcidiol2.svg | ImageAlt = カルシフェジオールの骨格式 | ImageFile1 = Calcifediol 3D ball.png | ImageAlt1 = カルシフェジオール分子のボール＆スティックモデル | PIN = (1''S'',3''Z'')-3-[(2''E'')-2-<nowiki/>{(1''R'',3a''S'',7a''R'')-1-[(2''R'')-6-Hydroxy-6-methylheptan-2-yl]-7a-methyloctahydro-4''H''-inden-4-ylidene}ethylidene]-4-methylidenecyclohexan-1-ol | O...")
20:40, 12 April 2024 Fire talk contribs created page Calcifediol/ja (Created page with "カルシフェジオール") Tags: Mobile edit Mobile web edit
20:39, 12 April 2024 Fire talk contribs created page Translations:Calcifediol/Page display title/ja (Created page with "カルシフェジオール")
20:39, 12 April 2024 Fire talk contribs marked Calcifediol for translation
20:39, 12 April 2024 Fire talk contribs set the priority languages for translatable page Calcifediol to Japanese
20:33, 12 April 2024 Fire talk contribs created page secondary hyperparathyroidism (Q22016) (wbeditentity-create:2|en: secondary hyperparathyroidism, human disease)
20:33, 12 April 2024 Fire talk contribs created page secondary hyperparathyroidism of renal origin (Q22015) (wbeditentity-create:2|en: secondary hyperparathyroidism of renal origin, Human disease)
20:30, 12 April 2024 Fire talk contribs created page rare genetic parathyroid disease and phosphocalcic metabolism disorder (Q22014) (wbeditentity-create:2|en: rare genetic parathyroid disease and phosphocalcic metabolism disorder, human disease)
20:28, 12 April 2024 Fire talk contribs created page rare genetic bone disease (Q22013) (wbeditentity-create:2|en: rare genetic bone disease, Rare genetic bone disease)
20:27, 12 April 2024 Fire talk contribs created page rare genetic bone development disorder (Q22012) (wbeditentity-create:2|en: rare genetic bone development disorder, human disease)
20:26, 12 April 2024 Fire talk contribs created page primary bone dysplasia (Q22011) (wbeditentity-create:2|en: primary bone dysplasia, human disease)
20:25, 12 April 2024 Fire talk contribs created page primary bone dysplasia with defective bone mineralization (Q22010) (wbeditentity-create:2|en: primary bone dysplasia with defective bone mineralization, human disease)
20:24, 12 April 2024 Fire talk contribs created page rare parathyroid disease and phosphocalcic metabolism anomaly (Q22009) (wbeditentity-create:2|en: rare parathyroid disease and phosphocalcic metabolism anomaly, human disease)
20:23, 12 April 2024 Fire talk contribs created page disorders of vitamin D metabolism (Q22008) (wbeditentity-create:2|en: disorders of vitamin D metabolism, human disease)
20:22, 12 April 2024 Fire talk contribs created page vitamin D deficiency (Q22007) (wbeditentity-create:2|en: vitamin D deficiency, human disease commonly occurring in people when they have inadequate sunlight exposure)
20:20, 12 April 2024 Fire talk contribs created page metabolic bone disease (Q22006) (wbeditentity-create:2|en: metabolic bone disease, disease)
20:17, 12 April 2024 Fire talk contribs created page (23S)-23,25-dihydroxycalciol (Q22005) (wbeditentity-create:2|en: (23S)-23,25-dihydroxycalciol, chemical compound)
20:15, 12 April 2024 Fire talk contribs created page 25-hydroxycholecalciferol-23-hydroxylase activity (Q22004) (wbeditentity-create:2|en: 25-hydroxycholecalciferol-23-hydroxylase activity, Catalysis of the reaction: calcidiol + 2 H(+) + O2 + 2 reduced [adrenodoxin] = (23S)-23,25-dihydroxycalciol + H2O + 2 oxidized [adrenodoxin].)
20:10, 12 April 2024 Fire talk contribs created page vasoconstriction (Q22003) (wbeditentity-create:2|en: vasoconstriction, narrowing of blood vessels by the constriction of smooth muscle cells)
20:09, 12 April 2024 Fire talk contribs created page vasoconstrictor agents (Q22002) (wbeditentity-create:2|en: vasoconstrictor agents, drugs used to cause constriction of the blood vessels)
10:49, 12 April 2024 Fire talk contribs created page calcium channel agonists (Q22001) (wbeditentity-create:2|en: calcium channel agonists, Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-se)
10:45, 12 April 2024 Fire talk contribs created page autoimmune skin disease (Q22000) (wbeditentity-create:2|en: autoimmune skin disease, hypersensitivity reaction type II disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the skin and connective tissue)
10:44, 12 April 2024 Fire talk contribs created page psoriasis (Q21999) (wbeditentity-create:2|en: psoriasis, skin disease)
10:43, 12 April 2024 Fire talk contribs created page antipsoriatic (Q21998) (wbeditentity-create:2|en: antipsoriatic, drug used to treat psoriasis)
10:40, 12 April 2024 Fire talk contribs created page hyperparathyroidism (Q21997) (wbeditentity-create:2|en: hyperparathyroidism, endocrine disease)
10:38, 12 April 2024 Fire talk contribs created page vitamin D 23-hydroxylase activity (Q21996) (wbeditentity-create:2|en: vitamin D 23-hydroxylase activity, Catalysis of the hydroxylation of C-23 of any form of vitamin D.)
10:37, 12 April 2024 Fire talk contribs created page 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity (Q21995) (wbeditentity-create:2|en: 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity, Catatlysis of the reaction: calcitriol + 2 H(+) + O2 + 2 reduced [adrenodoxin] = 1alpha,23S,25-trihydroxycholecalciferol + H2O + 2 oxidized [adrenodoxin].)
10:35, 12 April 2024 Fire talk contribs created page calcitriol binding (Q21994) (wbeditentity-create:2|en: calcitriol binding, Interacting selectively and non-covalently with calcitriol. Calcitriol (1,25-dihydroxycholecalciferol) is the hormonally active form of vitamin D3.)
10:30, 12 April 2024 Fire talk contribs created page calcitriol (Q21993) (wbeditentity-create:2|en: calcitriol, vitamin D)
10:26, 12 April 2024 Fire talk contribs created page calcidiol 1-monooxygenase activity (Q21992) (wbeditentity-create:2|en: calcidiol 1-monooxygenase activity, Catalysis of the reaction: calcidiol + H(+) + NADPH + O(2) = calcitriol + H(2)O + NADP(+).)
10:24, 12 April 2024 Fire talk contribs created page calcidiol binding (Q21991) (wbeditentity-create:2|en: calcidiol binding, Interacting selectively and non-covalently with calcidiol.)
10:20, 12 April 2024 Fire talk contribs created page calcifediol (Q21990) (wbeditentity-create:2|en: calcifediol, chemical compound)
10:18, 12 April 2024 Fire talk contribs created page Template:Calcium homeostasis/ja (Created page with "{{Navbox | name = Calcium homeostasis/ja | title = カルシウム恒常性 (H05) | state = {{{state<includeonly>|autocollapse</includeonly>}}} | listclass = hlist | group1 = 副甲状腺ホルモンとその類似体 | list1 = * Recombinant human parathyroid hormone/ja * Abaloparatide/ja * Teriparatide/ja | group2 = 抗副甲状腺ホルモン剤 | list2 = {{Navbox|sub...")
10:17, 12 April 2024 Fire talk contribs created page Template:Calcium homeostasis (Created page with "{{Navbox | name = Calcium homeostasis | title = Calcium homeostasis (H05) | state = {{{state<includeonly>|autocollapse</includeonly>}}} | listclass = hlist | group1 = Parathyroid hormone and analogues | list1 = * Recombinant human parathyroid hormone * Abaloparatide * Teriparatide | group2 = Anti-parathyroid hormone agents | list2 = {{Navbox|subgroup | group1 = Calcitonin derivatives | list1 = * Calcitonin * [...")
10:16, 12 April 2024 Fire talk contribs created page Calcifediol (Created page with "{{short description|Chemical compound}} {{chembox | Verifiedfields = changed | verifiedrevid = 480474501 | ImageFile = Calcidiol2.svg | ImageAlt = Skeletal formula of calcifediol | ImageFile1 = Calcifediol 3D ball.png | ImageAlt1 = Ball-and-stick model of the calcifediol molecule | PIN = (1''S'',3''Z'')-3-[(2''E'')-2-<nowiki/>{(1''R'',3a''S'',7a''R'')-1-[(2''R'')-6-Hydroxy-6-methylheptan-2-yl]-7a-methyloctahydro-4''H''-inden-4-ylidene}ethylidene]-4-methylidenecyclohexan-...")
10:09, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/34/ja (Created page with "研究者らは、この化合物は前世代の抗凝固殺鼠剤（ワルファリンやコンジェナー）やブロメタリンよりも非標的種に対する毒性が低く、リレー中毒（毒殺された動物を食べることによる中毒）は記録されていないと報告している。とはいえ、殺鼠剤中のコレカルシフェロール...")
10:08, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/33/ja (Created page with "高用量のコレカルシフェロールの機序は、「高カルシウム血症を引き起こし、その結果、軟部組織の全身石灰化が起こり、腎不全、心臓異常、高血圧、中枢神経系抑制、および消化器系不調を引き起こす。徴候は一般に摂取後18～36時間以内に発現し、抑うつ、食欲不振、polyuri...")
10:06, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/32/ja (Created page with "==殺虫剤{{Anchor|Pesticide}}== げっ歯類は他の種よりも高用量にやや弱く、コレカルシフェロールはこれらの害虫駆除のために毒餌に使用されてきた。")
10:05, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/31/ja (Created page with "==安定性== コレカルシフェロールはUV放射に非常に敏感で、速やかに、しかし可逆的に分解して超ステロールを形成し、さらに不可逆的にエルゴステロールに変換する。")
10:05, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/30/ja (Created page with "コレカルシフェロールは、地衣類からビタミンサプリメント用に工業生産もされており、菜食主義者にも適している。")
10:05, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/29/ja (Created page with "500px")
10:05, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/28/ja (Created page with "==工業生産{{Anchor|Industrial production}}== コレカルシフェロールは、ビタミンサプリメントや食品を強化するために工業的に生産されている。薬物としてはコレカルシフェロール（USAN）またはコレカルシフェロール（INN、BAN...")
10:03, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/27/ja (Created page with "ビタミンD<sub>3</sub>の合成と活性化の3つのステップは、以下のように調節されている： * コレカルシフェロールは、紫外線B（UVB）の作用により、皮膚で7-デヒドロコレステロールから合成される。コレカルシフェロールは、緯度、季節、雲量、高度によって決まる日光のUVBの強さと、皮膚の年齢と色素沈着の度合いによって、数分後に平衡に達する。 *...")
10:02, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/26/ja (Created page with "コレカルシフェロールとビタミンDのすべての形態が''ビタミン''の定義に含まれるかどうかは議論の余地がある。なぜなら、ビタミンの定義には、その物質が体内で合成されず、摂取しなければならないことが含まれているからだ。コレカルシフェロールは、UVB線に曝されたときに体内で合成される。")
10:00, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/25/ja (Created page with "コレカルシフェロールは、主にUVAスペクトルの紫外線を発生させる日焼けベッドのUVランプから放出される光によって皮膚で生成される可能性があるが、通常、UVBとして全紫外線放出の4％～10％を発生させる。日焼けサロンを頻繁に利用する人の血中濃度は高い。")
10:00, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/24/ja (Created page with "活性のあるUVB波長は太陽光に含まれており、太陽の強さにもよるが、皮膚を適度に露出させることで十分な量のコレカルシフェロールを生成することができる。時間帯、季節、緯度、標高は太陽の強さに影響し、汚染、雲、ガラスはすべてUVBの照射量を減少させる。顔、腕、脚を週に2回、平均5～30分浴びれば十分かもしれないが、肌の色が黒く、日差し...")
09:59, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/23/ja (Created page with "7-デヒドロコレステロールはコレカルシフェロールの前駆体である。皮膚の表皮層内で、7-デヒドロコレステロールは290～315 nmの波長のUVB光によって電気環式反応を起こし、295～300 nmの間に合成のピークが生じる。その結果、逆回転経路を...")
09:58, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/22/ja (Created page with "===生合成=== 右下のアイコンをクリックして開く。 {{VitaminDSynthesis_WP1531|highlight=Cholecalciferol}}")
09:58, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/21/ja (Created page with "===作用機序=== コレカルシフェロール自体は不活性である。それは2つの水酸化によって活性型に変換される：1つ目は肝臓で、CYP2R1またはCYP27A1によって、25-ヒドロキシコレカルシフェロール（カルシフェジオール、25-OHビタミンD<sub>3</sub>）を形成する。第二の水酸化は主に腎臓でCYP27B1の作用...")
09:56, 12 April 2024 Fire talk contribs created page Translations:Cholecalciferol/20/ja (Created page with "==生化学{{Anchor|Biochemistry}}== === 構造 === コレカルシフェロールはビタミンDの5つの形態のうちの1つである。コレカルシフェロールはセコステロイド、すなわち環が1つ開いたステロイド分子である。")